DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 89 filers reported holding DESIGN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,241 | +87.6% | 6,042 | +125.7% | 0.00% | – |
| Q1 2024 | $10,788 | -81.1% | 2,677 | -87.6% | 0.00% | -100.0% |
| Q4 2023 | $56,983 | +46.2% | 21,503 | +30.2% | 0.00% | 0.0% |
| Q3 2023 | $38,987 | +16.8% | 16,520 | +211.7% | 0.00% | 0.0% |
| Q2 2023 | $33,390 | +278150.0% | 5,300 | +152.5% | 0.00% | – |
| Q1 2023 | $12 | -63.6% | 2,099 | -35.2% | 0.00% | -100.0% |
| Q4 2022 | $33 | -100.0% | 3,241 | -64.0% | 0.00% | -50.0% |
| Q3 2022 | $151,000 | +77.6% | 9,010 | +48.7% | 0.00% | 0.0% |
| Q2 2022 | $85,000 | +1316.7% | 6,059 | +1453.6% | 0.00% | – |
| Q1 2022 | $6,000 | -77.8% | 390 | -69.3% | 0.00% | – |
| Q4 2021 | $27,000 | +285.7% | 1,271 | +185.0% | 0.00% | – |
| Q3 2021 | $7,000 | -83.3% | 446 | -79.1% | 0.00% | -100.0% |
| Q2 2021 | $42,000 | +250.0% | 2,129 | +434.9% | 0.00% | – |
| Q1 2021 | $12,000 | – | 398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |